Logo
x

Search

Subscribe Now

Moderna

Moderna’s mRESVIA (mRNA-1345) Vaccine Gains the EC’s Approval to Prevent Lower Respiratory Tract Disease (LTRD)

Moderna’s mRESVIA (mRNA-1345) Vaccine Gains the EC’s Approval to Prevent Lower Respiratory Tract Disease (LTRD)

  • August 27, 2024
Moderna’s mResvia (mRNA-1345) Gains the CHMP’s Positive Opinion to Prevent Lower Respiratory Tract Disease (LTRD)

Moderna’s mResvia (mRNA-1345) Gains the CHMP’s Positive Opinion to Prevent Lower Respiratory Tract Disease (LTRD)

  • June 27, 2024
Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19

Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19

  • June 14, 2024
Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19

Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19

  • June 11, 2024
Moderna Collaborates with OpenAI to Advance mRNA Medicine

Moderna Collaborates with OpenAI to Advance mRNA Medicine

  • April 26, 2024
Moderna and Merck Report Results from the P-IIb (KEYNOTE-942) Study of mRNA-4157 (V940) + Keytruda (pembrolizumab) for Resected High-Risk Melanoma

Moderna and Merck Report Results from the P-IIb (KEYNOTE-942) Study of mRNA-4157 (V940) + Keytruda (pembrolizumab) for Resected Hi...

  • December 15, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.